Failure of lithium treatment in established tardive dyskinesia
- PMID: 7003639
- DOI: 10.1017/s0033291700047498
Failure of lithium treatment in established tardive dyskinesia
Abstract
Eleven patients with tardive dyskinesia were treated with lithium carbonate in a placebo-controlled double-blind crossover study. No significant effect of lithium on either tardive dyskinesia or blood prolactin concentrations was demonstrated, but 5 patients developed pseudo-Parkinsonian features.
Similar articles
-
Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.Neuropsychobiology. 1978;4(3):140-9. doi: 10.1159/000117629. Neuropsychobiology. 1978. PMID: 340975 Clinical Trial.
-
Lithium and lecithin in tardive dyskinesia: an update.Psychiatry Res. 1986 Oct;19(2):101-4. doi: 10.1016/0165-1781(86)90002-8. Psychiatry Res. 1986. PMID: 3538109 Clinical Trial.
-
Lithium carbonate in the treatment of movement disorders. A critical review.Int Pharmacopsychiatry. 1980;15(5):301-8. doi: 10.1159/000468453. Int Pharmacopsychiatry. 1980. PMID: 6114936 Review.
-
Lithium in tardive dyskinesia.Pharmakopsychiatr Neuropsychopharmakol. 1976 Mar;9(2):76-80. doi: 10.1055/s-0028-1094481. Pharmakopsychiatr Neuropsychopharmakol. 1976. PMID: 790411 Clinical Trial.
-
In search of treatment for tardive dyskinesia: review of the literature.Schizophr Bull. 1979;5(2):251-93. doi: 10.1093/schbul/5.2.251. Schizophr Bull. 1979. PMID: 37597 Review.
Cited by
-
Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.Psychopharmacology (Berl). 1984;82(4):330-4. doi: 10.1007/BF00427680. Psychopharmacology (Berl). 1984. PMID: 6427824
-
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD000459. doi: 10.1002/14651858.CD000459.pub3. Cochrane Database Syst Rev. 2018. PMID: 29409162 Free PMC article.
-
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia.Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000208. doi: 10.1002/14651858.CD000208.pub2. Cochrane Database Syst Rev. 2018. PMID: 29552749 Free PMC article.
-
On the pathogenesis of abnormal involuntary movements in lithium-treated patients with major affective disorder.Eur Arch Psychiatry Clin Neurosci. 1991;241(1):1-7. doi: 10.1007/BF02193747. Eur Arch Psychiatry Clin Neurosci. 1991. PMID: 1832301
-
Lithium for schizophrenia.Cochrane Database Syst Rev. 2015 Oct 28;2015(10):CD003834. doi: 10.1002/14651858.CD003834.pub3. Cochrane Database Syst Rev. 2015. PMID: 26509923 Free PMC article.